Study to Determine The Effect of a Drug Called Neupogen on Stroke Recovery

NCT00809549 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Stroke

Interventions

DRUG: Filgrastim

Sponsor

Ottawa Hospital Research Institute